1. Home
  2. TRVI vs BBCP Comparison

TRVI vs BBCP Comparison

Compare TRVI & BBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • BBCP
  • Stock Information
  • Founded
  • TRVI 2011
  • BBCP 1983
  • Country
  • TRVI United States
  • BBCP United States
  • Employees
  • TRVI N/A
  • BBCP N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • BBCP Engineering & Construction
  • Sector
  • TRVI Health Care
  • BBCP Consumer Discretionary
  • Exchange
  • TRVI Nasdaq
  • BBCP Nasdaq
  • Market Cap
  • TRVI 383.4M
  • BBCP 318.8M
  • IPO Year
  • TRVI 2019
  • BBCP 2017
  • Fundamental
  • Price
  • TRVI $6.61
  • BBCP $6.86
  • Analyst Decision
  • TRVI Strong Buy
  • BBCP Buy
  • Analyst Count
  • TRVI 8
  • BBCP 4
  • Target Price
  • TRVI $17.56
  • BBCP $7.83
  • AVG Volume (30 Days)
  • TRVI 1.3M
  • BBCP 146.5K
  • Earning Date
  • TRVI 05-08-2025
  • BBCP 06-05-2025
  • Dividend Yield
  • TRVI N/A
  • BBCP N/A
  • EPS Growth
  • TRVI N/A
  • BBCP N/A
  • EPS
  • TRVI N/A
  • BBCP 0.28
  • Revenue
  • TRVI N/A
  • BBCP $414,608,000.00
  • Revenue This Year
  • TRVI N/A
  • BBCP N/A
  • Revenue Next Year
  • TRVI N/A
  • BBCP $6.18
  • P/E Ratio
  • TRVI N/A
  • BBCP $23.96
  • Revenue Growth
  • TRVI N/A
  • BBCP N/A
  • 52 Week Low
  • TRVI $2.30
  • BBCP $4.78
  • 52 Week High
  • TRVI $7.39
  • BBCP $9.68
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 56.38
  • BBCP 66.40
  • Support Level
  • TRVI $6.37
  • BBCP $5.98
  • Resistance Level
  • TRVI $7.24
  • BBCP $6.67
  • Average True Range (ATR)
  • TRVI 0.42
  • BBCP 0.29
  • MACD
  • TRVI -0.01
  • BBCP 0.07
  • Stochastic Oscillator
  • TRVI 50.38
  • BBCP 97.35

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About BBCP Concrete Pumping Holdings Inc.

Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.

Share on Social Networks: